Arcataur Capital Management’s Gilead Sciences GILD Stock Holding History

Arcataur Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$448K	Sell	3,544 -406	-10%	-$53.5K	0.11%	70
2026 Q1	$551K	Sell	3,950 -15	-0.4%	-$2.1K	0.15%	62
2025 Q4	$487K	Buy	3,965 +481	+14%	+$58.5K	0.14%	64
2025 Q3	$387K	Sell	3,484 -175	-5%	-$19.9K	0.11%	78
2025 Q2	$406K	Hold	3,659	–	–	0.13%	73
2025 Q1	$410K	Sell	3,659 -140	-4%	-$14.4K	0.14%	71
2024 Q4	$351K	Sell	3,799 -60	-2%	-$5.4K	0.12%	81
2024 Q3	$324K	Sell	3,859 -10	-0.3%	-$763	0.11%	85
2024 Q2	$265K	Sell	3,869 -35	-0.9%	-$2.34K	0.09%	91
2024 Q1	$286K	Hold	3,904	–	–	0.1%	87
2023 Q4	$316K	Buy	3,904 +800	+26%	+$62.3K	0.12%	79
2023 Q3	$233K	Hold	3,104	–	–	0.1%	87
2023 Q2	$239K	Buy	+3,104	New	+$248K	0.1%	89

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Arcataur Capital Management's GILD Position: Q2 2026 in Review

Arcataur Capital Management reduced its Gilead Sciences (GILD) stake by 10% in Q2 2026, selling an estimated $53.5K and leaving 3,544 shares worth $448K. The position accounts for 0.11% of the portfolio, ranked #70.

Arcataur Capital Management first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $551K in Q1 2026. 1,755 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Arcataur Capital Management held 3,544 shares of Gilead Sciences worth $448K as of Q2 2026.
Arcataur Capital Management sold 406 Gilead Sciences shares in Q2 2026, an estimated $53.5K.
Gilead Sciences made up 0.11% of Arcataur Capital Management's portfolio in Q2 2026, its #70 holding.
Arcataur Capital Management first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
Arcataur Capital Management's Gilead Sciences position peaked at $551K in Q1 2026.
1,755 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.